Chemours (CC)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$15.30-1.16%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
Broken: Primary pillar broken — Achieve free cash flow of at least $100 million in 2026: FCF guidance $50M vs $100M target.
Chemours aims to generate free cash flow of at least $100 million in 2026. Capital spending is disciplined, targeted between $275 million and $325 million. The company completed an acquisition recently, which may support growth. Management shows progress toward improved cash flow and earnings.
Chemours is selling off sharply and missed earnings in Q1 2026 with only 1% revenue growth. EPA regulation rollback raises oversupply concerns, threatening cash flow. The company remains loss-making with high risk and cautious signals.
The price is about 9% below our fair value near $21 and 28% below the Street median near $29. Analysts expect about 6.5% revenue growth, which is reasonable. Our view is cautious given the recent selloff and regulatory risks.
Breaks if: capital expenditures exceed 350 million USD or fall below 250 million USD in FY26
Breaks if: free cash flow falls below 50 million USD in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story in the materials sector. The current thesis state is mixed, reflecting both recent earnings misses and ongoing management priorities aimed at growth.
The market seems to have priced in a low expectations gap, indicating that investors are not overly optimistic about CC's near-term performance. The valuation is aligned with peers, though it carries a slight premium.
Management has set ambitious targets for sales growth and free cash flow, but recent financial performance has been weak. The mixed results in cash flow and sales indicate that the trajectory may remain volatile in the near term.
Key factors include management's ability to meet sales and cash flow targets, as well as external influences like inflation trends and performance of sector leaders. Any guidance cuts could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Signal changed from 'cautious' to 'mixed'.
Yes, our read has weakened. The latest earnings miss is a concern. A lawsuit could impact financial stability and reputation. These factors suggest a more negative outlook for the company.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Generate Free Cash Flow of at least $100 million for the full year 2026, supported by improved earnings and working capital management.
Stated as a priority in 3 of last 3 quarters. Free Cash Flows were $114 million in 2026-Q2 and negative $44 million in 2026-Q1, showing quarterly volatility but improvement from prior periods. Management targets at least $100 million Free Cash Flow for 2026 with conversion above 25%. The trajectory is mixed with progress in Q2 but negative cash flow in Q1.
“Free Cash Flows for the second quarter of 2026 were $114 million”
“Free Cash Flows for the first quarter of 2026 reflected a usage of $93 million”
“Free Cash Flows for the fourth quarter of 2025 were $92 million”
Breaks if: revenue falls below 750 million USD in FY26
Over the next 1 to 3 years, CC's performance will depend on execution against its targets and broader market conditions. Not investment advice.